Form 13-F position report

APOLLO MEDICAL HLDGS INC

Reported by VANGUARD GROUP INC

AMEH CUSIP 03763A207 Manager CIK 0000102909

Reported 5,049,928 shares, up 260,687 (5.4%) from the prior quarter.

Reported value 30.9%; share count 5.4% vs. the prior quarter.

Added
% of reported 13F value < 0.01% This manager · Q4 2023
Shares 5,049,928 Quarter-end amount reported
Reported value $193,412,242 Fair value at quarter end
Consecutive quarters held 23 Through Q4 2023

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-03-31 34480000
2021-06-30 109064000
2021-09-30 286530000
2021-12-31 286375000
2022-03-31 190293000
2022-06-30 162066000
2022-09-30 166389000
2022-12-31 131348679
2023-03-31 171892957
2023-06-30 149958654
2023-09-30 147748085
2023-12-31 193412242
2024-03-31 212478218
2024-06-30 191365609
2024-09-30 270301805
2024-12-31 147748287
2025-03-31 151917742
2025-06-30 120254594
2025-09-30 133842504
2025-12-31 105149543

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for APOLLO MEDICAL HLDGS INC held by VANGUARD GROUP INC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q4 2025 Reduced 4,238,192 -482,884 (-10.2%) < 0.01% $105,149,543 2026-01-29
Q3 2025 Reduced 4,721,076 -112,308 (-2.3%) < 0.01% $133,842,504 2025-11-07
Q2 2025 Reduced 4,833,384 -65,608 (-1.3%) < 0.01% $120,254,594 2025-08-11
Q1 2025 Added 4,898,992 +213,033 (4.5%) < 0.01% $151,917,742 2025-05-09
Q4 2024 Added 4,685,959 +20,757 (0.4%) < 0.01% $147,748,287 2025-02-11
Q3 2024 Reduced 4,665,202 -52,885 (-1.1%) < 0.01% $270,301,805 2024-11-13
Q2 2024 Reduced 4,718,087 -342,123 (-6.8%) < 0.01% $191,365,609 2024-08-13
Q1 2024 Added 5,060,210 +10,282 (0.2%) < 0.01% $212,478,218 2024-05-10
Q4 2023 Added 5,049,928 +260,687 (5.4%) < 0.01% $193,412,242 2024-02-14
Q3 2023 Added 4,789,241 +43,714 (0.9%) < 0.01% $147,748,085 2023-11-14
Q2 2023 Added 4,745,527 +32,257 (0.7%) < 0.01% $149,958,654 2023-08-14
Q1 2023 Added 4,713,270 +274,315 (6.2%) < 0.01% $171,892,957 2023-05-15
Q4 2022 Added 4,438,955 +172,563 (4.0%) < 0.01% $131,348,679 2023-02-10
Q3 2022 Added 4,266,392 +66,735 (1.6%) < 0.01% $166,389,000 2022-11-14
Q2 2022 Added 4,199,657 +273,681 (7.0%) < 0.01% $162,066,000 2022-08-12
Q1 2022 Added 3,925,976 +28,661 (0.7%) < 0.01% $190,293,000 2022-05-13
Q4 2021 Added 3,897,315 +750,357 (23.8%) < 0.01% $286,375,000 2022-02-14
Q3 2021 Added 3,146,958 +1,410,547 (81.2%) < 0.01% $286,530,000 2021-11-12
Q2 2021 Added 1,736,411 +463,617 (36.4%) < 0.01% $109,064,000 2021-08-13
Q1 2021 Added 1,272,794 +19,007 (1.5%) < 0.01% $34,480,000 2021-05-14
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

156 managers reported APOLLO MEDICAL HLDGS INC for Q4 2023.

Managers reporting APOLLO MEDICAL HLDGS INC in Q4 2023.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Reduced 6,498,075 -30,420 < 0.01% $248,876,273 23 qtrs
VANGUARD GROUP INC This report Added 5,049,928 +260,687 < 0.01% $193,412,242 23 qtrs
STATE STREET CORPORATION Reduced 1,546,620 -50,407 < 0.01% $59,235,546 23 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 944,449 +42,278 < 0.01% $36,176,355 23 qtrs
DIMENSIONAL FUND ADVISORS LP Added 768,520 +59,895 < 0.01% $29,437,651 22 qtrs
Steel Peak Wealth Management LLC Added 677,176 +65,000 1.5% $25,935,841 9 qtrs
325 CAPITAL LLC Unchanged 592,810 0 11.25% $22,704,623 6 qtrs
NORTHERN TRUST CORPORATION Reduced 452,732 -14,774 < 0.01% $17,339,635 23 qtrs
MORGAN STANLEY Added 391,199 +111,202 < 0.01% $14,982,922 25 qtrs
CHARLES SCHWAB INVESTMENT MANAGEMENT INC Added 344,029 +13,526 < 0.01% $13,176,311 23 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2023
Filed
February 14, 2024
Filing type
13F-HR
Position type
COM NEW

Voting authority reported

Sole
0
Shared
78,831
None
4,971,097

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.